Search

everythinglearnresearchcommunity

for

Search:↓

The user is experiencing hair loss at Norwood 2.5 and is using minoxidil, finasteride, and vitamins, noticing minimal regrowth after 8 months. They are considering using a dermaroller but are unsure of its effectiveness.

The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.

Verteporfin is being explored for hair regeneration, with unofficial trials and updates shared online. Efforts are being made to encourage more surgeons to trial verteporfin for donor hair regeneration.

The conversation discusses verteporfin as a potential treatment for hair regeneration, which could lead to unlimited hair transplants by healing the donor area. Some users are considering using verteporfin now, while others are hopeful it will be available for future hair transplants.

A user in their 20s is experiencing hair growth after two months of using minoxidil and finasteride, focusing on the hairline and temple areas. They also addressed vitamin deficiencies (B12, D3, and iron) and are considering additional treatments like derma stamping.

A 42-year-old experienced significant hair regrowth after 12 weeks on an oral combination of finasteride (1 mg) and minoxidil (2.5 mg), with noticeable improvements and no side effects. The user is considering continuing the treatment for a year due to the unexpected positive results.

Dr. Bloxham's 9-month update on FUT scar revision with Verteporfin shows promising results. Excitement is high for FUE, which appears highly effective based on Dr. Barghouthi's findings.

A user shared their positive experience using 2.5mg of finasteride daily for two years, noting significant hair regrowth and no erectile dysfunction issues. They plan to add minoxidil soon, despite some users suggesting that a lower dose of finasteride might be equally effective with fewer side effects.

A user is considering exosome therapy from Springs Rejuvenation for hair loss after unsuccessful attempts with PRP, adipose injections, and a laser cap. They are intrigued by the therapy's potential and the clinic's guarantee of 30% improved coverage, despite concerns about FDA approval and high-pressure sales tactics.

The conversation is about a user expressing concerns over the safety of a new drug called Pyrilutamide (also known as KX-826) for hair loss. The user will only trust the drug if it's permitted by EU regulations and sold by a reputable company.

PP405, a topical treatment, shows promise for hair growth by activating inactive follicles, with 66% of participants experiencing positive results. The treatment is well-tolerated and may proceed directly to Phase 3 trials, offering a potential alternative to minoxidil and finasteride.

The user reported significant hair regrowth after 2.5 months using 2.5 mg oral Minoxidil daily and 0.5 mg Dutasteride three times a week, along with betamethasone for scalp inflammation. They experienced minor side effects and are considering microneedling.

The user shared progress after two months using a topical formulation containing Dutasteride 0.25%, Minoxidil 5%, Cetirizine 1%, Melatonin 0.5%, Caffeine 2%, and Latanoprost 0.005%. The focus is on hair loss treatment results.

Doctors are testing verteporfin topically for healing and potential regeneration after transplants. The user is asking how it is formulated for topical use, such as if it's mixed with a carrier gel.

The conversation is about the availability of Koshine826 PRO 1% for hair loss treatment. The discussion includes Minoxidil, finasteride, and RU58841.

A user shared their 2-year hair recovery journey using minoxidil, microneedling, finasteride, iron, zinc, selenium, cyproterone, and estrogen. They started losing hair at 15 and are now 24.

Stemson Therapeutics announced a breakthrough in hair growth technology using stem cells. Users discussed the potential high cost and skepticism about the treatment's accessibility.

A user shared a 2-month update on their hair loss treatment, using dermarolling, Minoxidil, biotin, Nizoral, and castor oil, but not finasteride. Replies discuss reasons for delayed treatment and suggest considering a hair transplant.

HairClone aims to rejuvenate miniaturizing hair follicles through follicle banking and cell expansion, with treatments potentially available in the UK by 2022. The process involves extracting, storing, and cloning hair follicles, but full regenerative treatments will take many years to develop.

A user's success in treating their hair loss with 2x daily topical dutasteride and minoxidil, as well as the potential for using less frequent application of topical dutasteride due to its long half-life.

Hair cell therapy and follicle cloning are still in experimental stages, with treatments like hair multiplication and regenerative hair therapy being marketed but not yet proven to create unlimited new follicles. There is skepticism about the effectiveness and legitimacy of these treatments, with some considering them scams.

User started using minoxidil twice daily and microneedling every five days about 8-9 weeks ago. The post is about their progress with these treatments.

The user experienced significant hair regrowth over two years using topical minoxidil and oral finasteride, with no side effects from finasteride. Despite initial skepticism from others, the user confirmed the progress was not due to a hair transplant.

The user experienced significant hair regrowth using Rogaine foam, microneedling, Nizoral, liquid minoxidil, and topical finasteride over two years, with most progress in the last six months. They plan to evaluate their progress in the fall and consider a hair transplant if needed.

The potential release date for results from a phase 2 trial of Pyrilutamide, a hair loss treatment that combines Minoxidil, Finasteride and RU58841. It was agreed that the results are expected to be released in June 2022.

A hair restoration case involved injecting four different doses of Verteporfin into the mid scalp and using Scalp MicroPigmentation (SMP) around the extraction areas. Photos were taken and an update will be shared soon.

Dermal incision with verteporfin is being explored as a potential hair loss treatment by dermatologist Melissa Toyos, with promising before-and-after photos shared on social media. The conversation discusses its potential effectiveness compared to other treatments like Minoxidil, Finasteride, and RU58841.

Topical minoxidil and dermaroller use showed noticeable hair regrowth in two months and one week. Some users suggest adding finasteride for better results.

A user shared their positive two-month progress using a hair loss treatment plan including finasteride, minoxidil, dermarolling, ketoconazole shampoo, and vitamins. They noted significant hair regrowth and thickness improvement, attributing success to the combination of treatments.

Breezula's phase 2 showed reduced efficacy after 6 months, but phase 3 had positive results, causing confusion about any changes made to the drug. There is frustration over the long timeline for hair loss treatments, with some users expressing more interest in other potential treatments like GT-20029.